EBV Infection and Its Immune Control in Humanized Mice.

Curr Top Microbiol Immunol

Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Epstein Barr virus (EBV) was discovered 60 years ago as the first candidate human tumor virus. Since then, we have realized that this human γ-herpesvirus establishes persistent infection in the majority of adult humans but fortunately causes EBV associated diseases only in a few individuals. This is an incredible success story of the human immune system, which controls EBV infection and its transforming capacity for decades after initial virus encounter. A better understanding of this immune control would not only benefit patients with EBV associated malignancies but could also provide clues on how to establish such a potent, mostly cell-mediated immune control against other pathogens and tumors. However, the functional relevance of EBV specific immune responses can only be addressed in vivo and mice with reconstituted human immune system components (humanized mice) constitute a small animal model that can be infected with EBV, recapitulates some aspects of virus associated tumorigenesis, and mounts mostly cell-mediated immune responses against EBV. This chapter will summarize the insights into EBV immunobiology that have already been gained in humanized mouse models and provide an outlook into promising future avenues to further characterize EBV infection, immune control, and associated pathologies in vivo.

Download full-text PDF

Source
http://dx.doi.org/10.1007/82_2025_285DOI Listing

Publication Analysis

Top Keywords

immune control
16
ebv infection
12
ebv
10
immune
8
infection immune
8
humanized mice
8
ebv associated
8
human immune
8
immune system
8
cell-mediated immune
8

Similar Publications

Exploring Antiviral Strategies to Combat African Swine Fever.

FEMS Microbiol Rev

September 2025

CIISA - Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Lisbon, Portugal.

African Swine Fever (ASF), caused by the highly contagious African swine fever virus (ASFV), poses a significant threat to domestic and wild pigs worldwide. Despite its limited host range and lack of zoonotic potential, ASF has severe socio-economic and environmental consequences. Current control strategies primarily rely on early detection and culling of infected animals, but these measures are insufficient given the rapid spread of the disease.

View Article and Find Full Text PDF

In pig production, weaning is a critical period where piglets face several environmental stressors. This transition leads to a significant growth reduction and can result in digestive disorders, including diarrhea. To formulate a feed that meets zinc (Zn) and copper (Cu) requirements during the weaning period while minimizing their release into the environment, it became evident that a more bioavailable micro-mineral supplement is necessary.

View Article and Find Full Text PDF

Microbial cell-free DNA for diagnosis of bacterial and fungal infection in the immunocompromised host - what do we know?

Curr Opin Infect Dis

August 2025

Transplant and Immunocompromised Host Infectious Diseases, Department of Medicine, Infectious Diseases Division, Massachusetts General Hospital.

Purpose Of Review: Plasma metagenomic next-generation sequencing (mNGS) enables detection of microbial cell-free deoxyribonucleic acid (mcfDNA) in blood without the need for culture or organism-specific primers. Here, we review clinical performance, methodological variability, and real-world application of plasma mNGS for infectious disease diagnosis in immunocompromised hosts (ICHs).

Recent Findings: Plasma mNGS has rapidly gained attention as a novel diagnostic tool for infections in ICHs, offering broad-range pathogen detection from a noninvasive blood sample.

View Article and Find Full Text PDF

Background And Objectives: Deucravacitinib, a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor, demonstrated efficacy across the primary endpoint and all key secondary endpoints in the phase 2 PAISLEY SLE trial in patients with active systemic lupus erythematosus (SLE). Here, we describe 2 phase 3 trials [POETYK SLE-1 (NCT05617677), POETYK SLE-2 (NCT05620407)] which will assess the efficacy and safety of deucravacitinib in patients with active SLE. These phase 3 trials have been designed to replicate the successful elements of the phase 2 trial, including its glucocorticoid-tapering strategy and disease activity adjudication.

View Article and Find Full Text PDF

This study assessed the optimum dietary vitamin B requirement of Pacific white shrimp, Penaeus vannamei, for growth, feed efficiency, hemocyte counts, innate immunity, and ammonia stress resistance. Semi-purified experimental diets were prepared by adding vitamin B at 0.0, 0.

View Article and Find Full Text PDF